717
Participants
Start Date
April 4, 2013
Primary Completion Date
October 1, 2013
Study Completion Date
October 7, 2013
Umeclidinium bromide/Vilanterol
Dry white powder of UMEC 62.5 mcg per blister and VI 25 mcg per blister as NDPI with 30 doses (2 strips with 30 blisters per strip).
Placebo ACCUHALER/DISKUS
Dry white powder of matching placebo as multidose dry powder inhaler containing a foil strip with 60 blisters (1 strip with 60 blisters per strip).
Fluticasone propionate/Salmeterol
Dry white powder of fluticasone propionate 500 mcg per blister 50 mcg salmeterol per blister as multidose dry powder inhaler containing a foil strip with 60 blisters (1 strip with 60 blisters per strip).
Placebo NDPI
Dry white powder of matching placebo as NDPI with 30 doses (2 strips with 30 blisters per strip).
GSK Investigational Site, Budaörs
GSK Investigational Site, Gödöllő
GSK Investigational Site, Copenhagen
GSK Investigational Site, Hvidovre
GSK Investigational Site, Balassagyarmat
GSK Investigational Site, Miskolc
GSK Investigational Site, Szikszó
GSK Investigational Site, Roskilde
GSK Investigational Site, Debrecen
GSK Investigational Site, Debrecen
GSK Investigational Site, Nyíregyháza
GSK Investigational Site, Odense C
GSK Investigational Site, Szeged
GSK Investigational Site, Székesfehérvár
GSK Investigational Site, Farkasgyepű
GSK Investigational Site, Mosonmagyaróvár
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Schwerin
GSK Investigational Site, Ponferrada (León)
GSK Investigational Site, Madrid
GSK Investigational Site, Magdeburg
GSK Investigational Site, Valladolid
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Dillingen an der Donau
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Petrozavodsk
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Pertersburg
GSK Investigational Site, Kaluga
GSK Investigational Site, Ryazan
GSK Investigational Site, Saratov
GSK Investigational Site, Kazan'
GSK Investigational Site, Ufa
GSK Investigational Site, Orenburg
GSK Investigational Site, Nizhny Novgorod
GSK Investigational Site, Khantymansiysk
GSK Investigational Site, Barnaul
GSK Investigational Site, Blagoveshchensk
GSK Investigational Site, Benešov
GSK Investigational Site, Cvikov
GSK Investigational Site, Kralupy nad Vltavou
GSK Investigational Site, Kroměříž
GSK Investigational Site, Prague
GSK Investigational Site, Rokycany
GSK Investigational Site, Teplice
GSK Investigational Site, Třebíč
GSK Investigational Site, Delitzsch
GSK Investigational Site, Dresden
GSK Investigational Site, Pécs
GSK Investigational Site, Dordrecht
GSK Investigational Site, Eindhoven
GSK Investigational Site, Heerlen
GSK Investigational Site, Hoorn
GSK Investigational Site, Kloosterhaar
GSK Investigational Site, Sneek
GSK Investigational Site, Gdansk
GSK Investigational Site, Inowrocław
GSK Investigational Site, Krakow
GSK Investigational Site, Poznan
GSK Investigational Site, Skierniewice
GSK Investigational Site, Słupsk
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Tomsk
GSK Investigational Site, Barcelona
GSK Investigational Site, Alicante
GSK Investigational Site, L'Hospitalet de Llobregat
GSK Investigational Site, Pama de Mallorca
Lead Sponsor
GlaxoSmithKline
INDUSTRY